The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Research Report 2025
Synopsis
Increasing geriatric population across the globe coupled with increasing demand for cardiovascular, orthopaedic, digestive, and other surgical procedures is expected to fuel consumption of surgical hemostats, internal tissue sealants and adhesion barriers market.
The global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market was valued at US$ 4263.9 million in 2023 and is anticipated to reach US$ 7112.9 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers.
Report Scope
The Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
Ethicon
B. Braun Melsungen
Sanofi
C. R. Bard
Integra Lifesciences
Cryolife
Tissuemed
Cohera Medical
Pfizer
Segment by Type
Hemostats
Internal Tissue Sealants
Adhesion Barriers
Segment by Application
Hospitals
Clinics & Trauma Centers
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Increasing geriatric population across the globe coupled with increasing demand for cardiovascular, orthopaedic, digestive, and other surgical procedures is expected to fuel consumption of surgical hemostats, internal tissue sealants and adhesion barriers market.
The global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market was valued at US$ 4263.9 million in 2023 and is anticipated to reach US$ 7112.9 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers.
Report Scope
The Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
Ethicon
B. Braun Melsungen
Sanofi
C. R. Bard
Integra Lifesciences
Cryolife
Tissuemed
Cohera Medical
Pfizer
Segment by Type
Hemostats
Internal Tissue Sealants
Adhesion Barriers
Segment by Application
Hospitals
Clinics & Trauma Centers
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hemostats
1.2.3 Internal Tissue Sealants
1.2.4 Adhesion Barriers
1.3 Market by Application
1.3.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics & Trauma Centers
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Perspective (2019-2030)
2.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Growth Trends by Region
2.2.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Historic Market Size by Region (2019-2024)
2.2.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecasted Market Size by Region (2025-2030)
2.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Dynamics
2.3.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Industry Trends
2.3.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Drivers
2.3.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Challenges
2.3.4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Players by Revenue
3.1.1 Global Top Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Players by Revenue (2019-2024)
3.1.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Players (2019-2024)
3.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue
3.4 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Concentration Ratio
3.4.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue in 2023
3.5 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Key Players Head office and Area Served
3.6 Key Players Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Solution and Service
3.7 Date of Enter into Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Breakdown Data by Type
4.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Historic Market Size by Type (2019-2024)
4.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecasted Market Size by Type (2025-2030)
5 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Breakdown Data by Application
5.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Historic Market Size by Application (2019-2024)
5.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size (2019-2030)
6.2 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2019-2024)
6.4 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size (2019-2030)
7.2 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2019-2024)
7.4 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size (2019-2030)
8.2 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region (2019-2024)
8.4 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size (2019-2030)
9.2 Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2019-2024)
9.4 Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size (2019-2030)
10.2 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2019-2024)
10.4 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baxter
11.1.1 Baxter Company Detail
11.1.2 Baxter Business Overview
11.1.3 Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.1.4 Baxter Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
11.1.5 Baxter Recent Development
11.2 Ethicon
11.2.1 Ethicon Company Detail
11.2.2 Ethicon Business Overview
11.2.3 Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.2.4 Ethicon Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
11.2.5 Ethicon Recent Development
11.3 B. Braun Melsungen
11.3.1 B. Braun Melsungen Company Detail
11.3.2 B. Braun Melsungen Business Overview
11.3.3 B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.3.4 B. Braun Melsungen Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
11.3.5 B. Braun Melsungen Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.4.4 Sanofi Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 C. R. Bard
11.5.1 C. R. Bard Company Detail
11.5.2 C. R. Bard Business Overview
11.5.3 C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.5.4 C. R. Bard Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
11.5.5 C. R. Bard Recent Development
11.6 Integra Lifesciences
11.6.1 Integra Lifesciences Company Detail
11.6.2 Integra Lifesciences Business Overview
11.6.3 Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.6.4 Integra Lifesciences Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
11.6.5 Integra Lifesciences Recent Development
11.7 Cryolife
11.7.1 Cryolife Company Detail
11.7.2 Cryolife Business Overview
11.7.3 Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.7.4 Cryolife Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
11.7.5 Cryolife Recent Development
11.8 Tissuemed
11.8.1 Tissuemed Company Detail
11.8.2 Tissuemed Business Overview
11.8.3 Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.8.4 Tissuemed Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
11.8.5 Tissuemed Recent Development
11.9 Cohera Medical
11.9.1 Cohera Medical Company Detail
11.9.2 Cohera Medical Business Overview
11.9.3 Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.9.4 Cohera Medical Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
11.9.5 Cohera Medical Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.10.4 Pfizer Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
11.10.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Hemostats
Table 3. Key Players of Internal Tissue Sealants
Table 4. Key Players of Adhesion Barriers
Table 5. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Region (2019-2024)
Table 9. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Region (2025-2030)
Table 11. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Trends
Table 12. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Drivers
Table 13. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Challenges
Table 14. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Restraints
Table 15. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Players (2019-2024)
Table 17. Global Top Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers as of 2023)
Table 18. Ranking of Global Top Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Solution and Service
Table 22. Date of Enter into Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Type (2019-2024)
Table 26. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Type (2025-2030)
Table 28. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Application (2019-2024)
Table 30. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Application (2025-2030)
Table 32. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2025-2030) & (US$ Million)
Table 47. Baxter Company Detail
Table 48. Baxter Business Overview
Table 49. Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 50. Baxter Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024) & (US$ Million)
Table 51. Baxter Recent Development
Table 52. Ethicon Company Detail
Table 53. Ethicon Business Overview
Table 54. Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 55. Ethicon Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024) & (US$ Million)
Table 56. Ethicon Recent Development
Table 57. B. Braun Melsungen Company Detail
Table 58. B. Braun Melsungen Business Overview
Table 59. B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 60. B. Braun Melsungen Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024) & (US$ Million)
Table 61. B. Braun Melsungen Recent Development
Table 62. Sanofi Company Detail
Table 63. Sanofi Business Overview
Table 64. Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 65. Sanofi Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024) & (US$ Million)
Table 66. Sanofi Recent Development
Table 67. C. R. Bard Company Detail
Table 68. C. R. Bard Business Overview
Table 69. C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 70. C. R. Bard Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024) & (US$ Million)
Table 71. C. R. Bard Recent Development
Table 72. Integra Lifesciences Company Detail
Table 73. Integra Lifesciences Business Overview
Table 74. Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 75. Integra Lifesciences Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024) & (US$ Million)
Table 76. Integra Lifesciences Recent Development
Table 77. Cryolife Company Detail
Table 78. Cryolife Business Overview
Table 79. Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 80. Cryolife Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024) & (US$ Million)
Table 81. Cryolife Recent Development
Table 82. Tissuemed Company Detail
Table 83. Tissuemed Business Overview
Table 84. Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 85. Tissuemed Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024) & (US$ Million)
Table 86. Tissuemed Recent Development
Table 87. Cohera Medical Company Detail
Table 88. Cohera Medical Business Overview
Table 89. Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 90. Cohera Medical Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024) & (US$ Million)
Table 91. Cohera Medical Recent Development
Table 92. Pfizer Company Detail
Table 93. Pfizer Business Overview
Table 94. Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 95. Pfizer Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024) & (US$ Million)
Table 96. Pfizer Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Type: 2023 VS 2030
Figure 3. Hemostats Features
Figure 4. Internal Tissue Sealants Features
Figure 5. Adhesion Barriers Features
Figure 6. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics & Trauma Centers Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Report Years Considered
Figure 12. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Region: 2023 VS 2030
Figure 15. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Players in 2023
Figure 16. Global Top Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue in 2023
Figure 18. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Country (2019-2030)
Figure 20. United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Country (2019-2030)
Figure 24. Germany Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Region (2019-2030)
Figure 32. China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Country (2019-2030)
Figure 40. Mexico Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Country (2019-2030)
Figure 44. Turkey Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Baxter Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
Figure 47. Ethicon Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
Figure 48. B. Braun Melsungen Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
Figure 49. Sanofi Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
Figure 50. C. R. Bard Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
Figure 51. Integra Lifesciences Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
Figure 52. Cryolife Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
Figure 53. Tissuemed Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
Figure 54. Cohera Medical Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
Figure 55. Pfizer Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
